HuagongsheHuagongshe Chemistry Print Report · For research reference only
4-[2-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]benzoic Acid → HCID 10118990, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 4-[2-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]benzoic Acid | HCID 11220119 | — |
| Reactant | HCID 18545753 | HCID 18545753 | — |
| Product | HCID 10118990 | HCID 10118990 | — |
Reaction Steps
2′-Methyl-5′-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[2-(4-sulphamoylphenyl)phenyl]-1,1′-biphenyl-4-carboxamide was prepared from 2′-methyl-5′-(5-methyl-1,3,4-oxadiazol-2-yl)-1,1′-biphenyl-4-carboxylic acid and 4-(2-aminophenyl)phenylsulphonamide using method I. LCMS; retention time 3.16 min, MH+ 525.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07384963B2 |
| Source dataset | uspto-grants-2008_06 |
| ORD ID | ord-dccd4080649d4301b54840baf2f3e343 |
| Source note | uspto-grants-2008_06 |